Importance
A substantial proportion of patients with atrial fibrillation (AF) die of non-cardiovascular causes, and recent studies suggest a link between AF and cancer.
Objective
To evaluate the relationships between AF and cancer in a large, long term prospective cohort study.
Design, Setting and participants
A total of 34’691 women aged ≥45 years and free of AF, cardiovascular disease and cancer at baseline were prospectively followed between 1993 and 2014 for incident AF and malignant cancer within the Women’s Health Study, a randomized trial of aspirin and Vitamin E for the prevention of cardiovascular disease and cancer. Cox proportional-hazards models using time-updated covariates were constructed to assess the relationship of new-onset AF with subsequent cancer and to adjust for potential confounders.
Exposure
New-onset AF
Main outcome measure
Incident malignant cancer confirmed by an endpoint committee.
Results
During 19.1 years of follow-up, AF was a significant risk factor for incident cancer in age-adjusted (hazard ratio (HR) 1.58, 95% confidence interval (CI), 1.34, 1.87, p<0.0001) and multivariable adjusted (HR 1.48, 95% CI, 1.25, 1.75, p<0.001) models. The relative risk of cancer was highest in the first 3 months after new-onset AF (HR 3.54, 95% CI 2.05, 6.10, p<0.001) but remained significant beyond 1 year after new-onset AF (adjusted HR 1.42, 95% CI 1.18, 1.71, p<0.001), and a trend toward an increased cancer mortality was observed (adjusted HR 1.32, 95% CI 0.98, 1.79, p=0.07). In contrast, among women with new onset cancer, the relative risk of AF was increased only within the first 3 months (HR 4.67, 95% CI 2.85, 7.64, p<0.001) but not thereafter (HR 1.15, 95% CI 0.95, 1.39, p=0.15).
Conclusions and relevance
In this large initially healthy cohort, women with new-onset AF had an elevated cancer risk beyond one year of AF diagnosis. Shared risk factors and/or common systemic disease processes might underlie this association.